Wave Life Sciences Ltd. — Director's Dealing 2025

Mar 8, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2025-03-07

Reporting Person: BOLNO PAUL (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-07	Ordinary Shares	M	169025	$2.48	Acquired	507376	Direct
2025-03-07	Ordinary Shares	S	169025	$9.57	Disposed	338351	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-07	Share Option (right to buy)	$2.48	M	120966	Disposed	2025-03-10	Ordinary Shares (120966)	Direct
2025-03-07	Share Option (right to buy)	$2.48	M	48059	Disposed	2025-03-10	Ordinary Shares (48059)	Direct

Footnotes

F1: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.

F2: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.12 to $10.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3: These share options are fully vested and have an expiration date of Monday, March 10, 2025.